New Large-Vessel heart stent tested in Real-World patients
NCT ID NCT05423379
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at a special stent (a small mesh tube) coated with the drug everolimus, designed for large coronary arteries. It involves 102 people with coronary artery disease who need a stent. The goal is to see how safe and effective the stent is in everyday medical practice, tracking events like heart attacks or the need for repeat procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
everolimus-eluting coronary stent
What this could lead to
If successful, this could confirm that the larger stent is a safe and effective option for treating blocked large coronary arteries, expanding treatment choices.
What could go wrong
This is an observational study without a comparison group, so results may not prove superiority over other stents. Risks include typical stent complications like blood clots or re-narrowing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anmed Health
Anderson, South Carolina, 29621, United States
-
Arkansas Heart Hospital
Little Rock, Arkansas, 72211, United States
-
Austin Heart
Austin, Texas, 78756, United States
-
Bryan Heart
Lincoln, Nebraska, 68506, United States
-
Clinique Pasteur Toulouse
Toulouse, Midi-Pyrenees, 31300, France
-
Greenville Health System
Greenville, South Carolina, 29605-5601, United States
-
Hendrick Medical Center
Abilene, Texas, 79601, United States
-
Hopital Cardiovasculaire et Pneumologique Louis Pradel
Lyon, Rhone, France
-
Hospital Clinico San Carlos
Madrid, Madrid, Spain
-
Hospital Universitario Marqués de Valdecilla
Santander, Spain
-
Hospital Virgen de Rocio
Seville, Spain
-
Lenox Hill Hospital
New York, New York, 10075, United States
-
Memorial Hospital Jacksonville
Jacksonville, Florida, 32216, United States
-
Pinnacle Health System
Wormleysburg, Pennsylvania, 17043, United States
-
Shannon Clinic
San Angelo, Texas, 76903, United States
-
Tallahassee Research Institute
Tallahassee, Florida, 32308, United States
-
The Heart Hospital Baylor Plano
Plano, Texas, 75074, United States
-
Via Christi Regional Medical Center - St. Francis Campus
Wichita, Kansas, 67226, United States